U.S. Senators Question FDA’s Approval of JUUL, Demand Full Data and Review Records by Deadline

Key points:

·Focus Event: FDA approval of Juul e-cigarette market entry sparks collective opposition from Democratic senators, demanding explanation of decision-making basis. 

·Controversy: FDA's reversal of Juul product sales ban in 2024 is alleged to involve conflicts of interest between the Trump administration and the e-cigarette industry, citing evidence of former Trump advisor's responsibility for Juul federal lobbying. 

·Background information: Juul has reached over $1.1 billion in settlements with 48 states and regions for misleading advertising. 

·Progress: Senators request FDA to respond to related questions by August 22nd.

【2Firsts News Flash】According to a report by CSP on August 4th, a group of federal lawmakers are opposing the US FDA's decision to issue market access permits (MGOs) for Juul e-cigarettes.

Eight Democratic senators have jointly asked the FDA to explain its decision to approve the Juul e-cigarette, including its mint-flavored electronic pods.

They wrote to FDA Commissioner Marty Makary on July 28, requesting the agency to explain the decision to allow Juul e-cigarettes to continue being sold on the market.

In 2024, the FDA lifted the market denial orders (MDOs) for all products sold by Juul Labs in the United States.

Senators said in a letter:

“We are deeply concerned about the signs of conflicting interests between the Trump administration and the American e-cigarette industry regarding this policy reversal.”

The letter also mentioned:

“For example, former public health and science advisor to President Trump is now responsible for Juul's federal lobbying efforts.”

These federal lawmakers stated that the Washington-based e-cigarette company has reached settlement agreements with 48 states and territories, paying a total amount of over $1.1 billion for its misleading advertising.

Senate Democratic Whip Dick Durbin and other senators are requesting responses to a series of questions by August 22nd, as stated in a letter.